SSI Ranked KLAS Category Leader For Third Consecutive Year

The SSI Group, Inc. (SSI) is pleased to announce their medical billing software has been selected as the KLAS Category Leader in the “2014 Best in KLAS Awards: Software & Services” report. The publication’s announcement for 2014 marks the third consecutive year that SSI's Billing solution has excelled in the "Revenue Cycle - Claims Management" market segment.

“We are honored to have maintained the distinction of KLAS Category Leader for the SSI Billing solution for a third year,” said Jimmy Lyons, SSI President and CEO. “KLAS provides an invaluable forum for customer feedback to be collected, analyzed and relayed to our organization, enabling us to improve our software and services. We are grateful for both the feedback of our customers, and the efforts of the KLAS organization to contribute to our mission of providing exceptional service and solutions to our customers.”

About SSI
SSI is a forward-thinking innovator that is powering the business of healthcare through improved flexibility, connectivity and integration. The company offers an end-to-end Revenue Cycle Management (RCM) solution featuring front-end eligibility, industry- leading billing and claims management, contract management, release of information, audit defense, document management, workflow, advanced analytics and denial management. With over 800 direct payer connections through its EHNAC-certified clearinghouse, SSI processes 600 million transactions annually, totaling in excess of $800B. For more information, visit www.thessigroup.com.

About KLAS
KLAS is a research firm on a global mission to improve healthcare delivery by enabling providers to be heard and counted. Working with thousands of healthcare professionals and clinicians, KLAS gathers data on software, services, medical equipment, and infrastructure systems to deliver timely reports, trends, and statistical overviews. The research directly represents the provider voice and acts as a catalyst for improving vendor performance.